Orange Book product
IBUPROFEN 300MG
Orange Book ANDA 202413 · SHANDONG XINHUA PHARMACEUTICAL CO LTD · Prescription
Key facts
| Proprietary name | IBUPROFEN |
|---|---|
| Active ingredients | IBUPROFEN |
| Strength | 300MG |
| Dosage form | TABLET |
| Route | ORAL |
| Application | ANDA202413 |
| Applicant holder | SHANDONG XINHUA PHARMACEUTICAL CO LTD |
| Marketing status | Prescription |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Jul 5, 2024 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.